Neurological conditions

Considerations for the inpatient management of Parkinson’s disease

Recognising and managing certain complications of Parkinson’s disease can help improve care and reduce the risk of admission for people living with the condition.…

Trial confirms antiepileptic effects of fenfluramine in children with Dravet syndrome

Children with Dravet syndrome, a severe form of epilepsy that is resistant to treatment, experience fewer seizures when treated with fenfluramine, a phase III trial published in The Lancet has confirmed.…

Multimodal exercise improves Parkinson’s disease symptoms

Exercise plans involving both physical and mental challenges, may improve outcomes in people with Parkinson’s disease, research presented at the Future Physiology conference has shown.…

Drug interaction may explain cannabidiol’s effects on severe form of epilepsy

A drug–drug interaction between cannabidiol and clobazam may explain why cannabidiol reduces the frequency of seizures in patients with a severe form of epilepsy, researchers have reported.…

Accord’s phenytoin sodium 100mg capsules out of stock until early May 2020

The pharmaceutical manufacturer Accord has said that its phenytoin sodium NRIM 100mg capsules, used for the management of epilepsy, will be out of stock until early May 2020.…

European Commission approves first CBD medicine for severe epilepsy

A cannabidiol-based medicine for severe epilepsy has been given marketing approval by the European Commission.…

NICE cannabis guidance could ‘detract’ from doctors considering prescribing for epilepsy, RPS warns

NICE cannabis guidance could deter doctors from prescribing for epilepsy, RPS warns Source: Shutterstock.com Cannabis-based medical products are legal for use in the treatment of some forms of severe treatment-resistant epilepsy Draft guidance is…

Shortage of epilepsy medicine to continue until end of October, manufacturer says

All strengths of the epilepsy medicine Gabitril will be out of stock in the UK until the end of October 2019, the drug’s manufacturer has said.…

NHS guidance on progressive neurological conditions calls for more input from specialist pharmacists

Including specialist pharmacists in multidisciplinary care teams for patients with Parkinson’s disease and multiple sclerosis could help to avoid up to 2,500 emergency admissions to hospital each year, according to NHS England.…

Cannabis-derived medicine for treatment of two rare forms of epilepsy approved by EMA committee

A European Medicines Agency committee has given a positive opinion for what could be the first plant-derived cannabis-based medicine to be approved in Europe for the treatment of any form of epilepsy.…